Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

3 2.2 Survey of key experts (KE) The second component of the IDRS involves semi-structured interviews with key experts (KE), selected because their work brings them into regular contact with illicit drug users. Criteria for inclusion in this part of the study are at least weekly contact with illicit drug users in the past six months or contact with a minimum of 10 illicit drug users during the same period. Information from KE corroborates data from participants, but also provides a broader context in which to place the participants data. A standardised interview schedule is used by all states and territories that closely mirrors the participants questionnaire. Each KE is asked to nominate the main illicit drug used by most of the illicit drug users they work with and information is then gathered about use, availability, price and purity of that drug category. Further questions are asked about health, treatment, crime and police activity. In Darwin and Palmerston, interviews were conducted with 13 KE during July and August 2011. Interviews were conducted either by telephone or on a face to face basis. KE, and the main drug or drugs they discussed, were drawn from the following fields: AOD workers Opiate Pharmacotherapy Program Opioids Opiate Pharmacotherapy Program Opioids OPP Sessional Medical Officer Opioids (and methamphetamine) Hospital AOD liaison worker Opioids (and cannabis) Withdrawal Service worker Opioids NGO Rehabilitation provider Cannabis NGO Rehabilitation provider Methamphetamine Needle and Syringe Program worker Opioids Needle and Syringe Program worker Methamphetamine The Opiate Pharmacotherapy Program workers, the Opiate Pharmacotherapy Program Sessional Medical Officer, the Hospital AOD liaison worker and the Withdrawal Service worker were employed by the Northern Territory Governments Alcohol and Other Drugs Program. Both NGO Rehabilitation providers were employed within an outpatient counselling service and the NSP workers were employed by the Northern Territory Aids and Hepatitis Council. Law Court clinician Opioids Court clinician Methamphetamine (and cannabis) Police officer Cannabis Police officer Methamphetamine (and cannabis) The court clinicians were employed by the Northern Territory Department of Justice and the police officers were employed by the Northern Territory Police, Fire and Emergency Service Drug and Organised Crime Division. Interviews took between 40 minutes and 60 minutes. Notes were taken at the time of interview and later transcribed and analysed for recurring themes.


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.